Donor Lymphocyte Infusion After Allogeneic Hematopoietic Cell Transplantation for High-Risk Hematologic Malignancies
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
Hope Biosciences Research Foundation
Pharmacyclics LLC.
Kyowa Kirin Co., Ltd.
Fate Therapeutics
Alexion Pharmaceuticals, Inc.
Pharmacyclics LLC.
M.D. Anderson Cancer Center
Dana-Farber Cancer Institute
Genta Incorporated